ALK and B-cell non-Hodgkin lymphoma: The algorithm showed heterogeneous performance in T-cell lymphomas compared to B-cell lymphomas, except for ALCL and ALK-positive, which showed no error in presumptive diagnosis in all datasets (training, validation, and external validation).